# ALSERES PHARMACEUTICALS INC /DE

ALSERES PHARMACEUTICALS INC /DE is a company headquartered in Auburndale, MA, United States.

## Company overview

- **Legal name:** ALSERES PHARMACEUTICALS INC /DE
- **Former names in filing history:** BOSTON LIFE SCIENCES INC /DE (1996-07-19 to 2007-05-15)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Auburndale, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0000094784

## About

ALSERES PHARMACEUTICALS INC /DE is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000094784, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2014-04-10, it reported annual revenue of USD 473,730; net income of USD -941,529; total assets of USD 385,471 for the fiscal period ended 2013-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2013 (period ended 2013-12-31)

- **Revenue:** $473,730 (USD 473,730)
- **Net income:** -$941,529 (USD -941,529)
- **Total assets:** $385,471 (USD 385,471)
- **Cash and equivalents:** $113,958 (USD 113,958)
- **Operating cash flow:** -$1.7M (USD -1,686,929)

### FY2012 (period ended 2012-12-31)

- **Revenue:** $530,720 (USD 530,720)
- **Net income:** -$1.6M (USD -1,645,476)
- **Total assets:** $965,707 (USD 965,707)
- **Cash and equivalents:** $16,528 (USD 16,528)
- **Operating cash flow:** -$952,449 (USD -952,449)

### FY2011 (period ended 2011-12-31)

- **Net income:** -$2.9M (USD -2,882,214)
- **Total assets:** $170,729 (USD 170,729)
- **Cash and equivalents:** $135,843 (USD 135,843)
- **Operating cash flow:** -$2.5M (USD -2,484,803)

## Recent SEC filings

- Form 8-K — filed 2014-11-21 — period 2014-11-17 — 8-K
- Form 10-Q — filed 2014-08-14 — period 2014-06-30 — 10-Q
- Form 10-Q — filed 2014-05-23 — period 2014-03-31 — FORM 10-Q
- Form 10-K — filed 2014-04-10 — period 2013-12-31 — 10-K
- Form 8-K — filed 2014-01-06 — period 2013-12-31 — 8-K
- Form 8-K — filed 2013-12-17 — period 2013-12-12 — 8-K
- Form 10-Q — filed 2013-11-14 — period 2013-09-30 — 10-Q
- Form 10-Q — filed 2013-08-09 — period 2013-06-30 — FORM 10-Q
- Form 8-K — filed 2013-07-31 — period 2013-07-30 — 8-K
- Form 10-Q — filed 2013-05-17 — period 2013-03-31 — FORM 10-Q
- Form 10-K — filed 2013-04-01 — period 2012-12-31 — FORM 10-K
- Form 8-K — filed 2013-02-21 — period 2013-02-15 — FORM 8-K

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/alseres-pharmaceuticals-inc-de

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology